Mitsubishi Tanabe Pharma is Pharmaceuticals in Japan that focus on the-counter drugs business. They cover business area such as Mitsubishi Tanabe Pharma Corp, development, manufacturing, procurement, sale, pharmaceutical, Pharmaceuticals segment, business activity, ethical drug, the-counter, Kremezin, BindRen, Lexapro, Diabetic nephropathy, chronic kidney disease, hyperphosphatemia, depression, Japan, its business.
-
The-counter Drugs
-
2-6-18, Kitahama
Chuo-ku
Doshomachi, Osaka 541-8505
Japan
Private
Mitsubishi Tanabe Pharma CorpdevelopmentmanufacturingprocurementsalepharmaceuticalPharmaceuticals segmentbusiness activityethical drugthe-counterKremezinBindRenLexaproDiabetic nephropathychronic kidney diseasehyperphosphatemiadepressionJapanits business
* We use standard office opening hours in near Mitsubishi Tanabe Pharma's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Mitsubishi Tanabe Pharma is Pharmaceuticals business from Japan that founded in - ( years old in ), Mitsubishi Tanabe Pharma business is focusing on The-counter Drugs.
Mitsubishi Tanabe Pharma headquarter office and corporate office address is located in 2-6-18, Kitahama Chuo-ku Doshomachi, Osaka 541-8505 Japan.
Mitsubishi Tanabe Pharma was founded in Japan.
In , Mitsubishi Tanabe Pharma is currently focus on the-counter drugs sector.
Above is snippet of Google Trends for "the-counter drugs" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Mitsubishi Tanabe Pharma, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
